CN101450162A - Traditional Chinese medicine composition with blood-sugar reduction function and preparation method thereof - Google Patents

Traditional Chinese medicine composition with blood-sugar reduction function and preparation method thereof Download PDF

Info

Publication number
CN101450162A
CN101450162A CNA2007101785080A CN200710178508A CN101450162A CN 101450162 A CN101450162 A CN 101450162A CN A2007101785080 A CNA2007101785080 A CN A2007101785080A CN 200710178508 A CN200710178508 A CN 200710178508A CN 101450162 A CN101450162 A CN 101450162A
Authority
CN
China
Prior art keywords
chinese medicine
medicine composition
fructus momordicae
tea polyphenols
momordicae charantiae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007101785080A
Other languages
Chinese (zh)
Inventor
谭剑平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Increase Pharmaceutical Technology Co Ltd
Original Assignee
Beijing Increase Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Increase Pharmaceutical Technology Co Ltd filed Critical Beijing Increase Pharmaceutical Technology Co Ltd
Priority to CNA2007101785080A priority Critical patent/CN101450162A/en
Publication of CN101450162A publication Critical patent/CN101450162A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition with hypoglycemic function and preparation method thereof. The traditional Chinese medicine is made from balsam pear, Chinese yam and tea polyphenol according to a certain weight proportion; and it can be made into any common oral taken preparation form. The Chinese traditional medicine composition in the invention achieves hypoglycemic function, and can be used in auxiliary treatment of diabetes.

Description

A kind of Chinese medicine composition and preparation method thereof with function of blood sugar reduction
Technical field
The wood invention relates to a kind of Chinese medicine composition with function of blood sugar reduction and preparation method thereof, belongs to Chinese medicine and field of health care food.
Background technology
Diabetes are the one group of Developmental and Metabolic Disorder syndromes that is caused by the h and E factor interaction.Long-term diabetes can cause the chronic complicating diseases of a plurality of systems organ, cause dysfunction and depletion, become disable, lethal main cause.At present, the prevalence of diabetes had the trend of remarkable rising in recent years in the population of China.Because the cause of disease and the pathogenesis of diabetes are not clear fully as yet, therefore also lack effective etiological treatment method at present.Clinically treatment of diabetes is adopted insulinize and oral hypoglycemic drug therapy more now, yet diabetes spp is in a kind of lifelong participation disease, need long-term prescription, the drug administration by injection method of insulin tends to bring many inconvenience to the patient, and clinical orally-taken blood sugar reducing medicine commonly used belongs to chemical drugs more, takes for a long time also and can cause a series of untoward reaction.In view of there being above problem, so exploitation a kind of blood sugar lowering Chinese medicine and health food safe, effective, that be suitable for taking for a long time are badly in need of on present market very much.
Summary of the invention
The object of the invention just provides a kind of Chinese medicine composition with function of blood sugar reduction.
Another object of the present invention has provided the preparation method of this Chinese medicine composition.
The present invention is achieved by the following technical solutions:
The present invention is made by the following weight proportion raw material:
Fructus Momordicae charantiae 5-30 part, Rhizoma Dioscoreae 5-30 part, tea polyphenols 0.1-1.5 part.
Be preferably:
Fructus Momordicae charantiae 5-15 part, Rhizoma Dioscoreae 15-30 part, tea polyphenols 0.3-0.8 part.
The best is:
10 parts in Fructus Momordicae charantiae, 20 parts of Rhizoma Dioscoreaes, 0.5 part of tea polyphenols.
The preparation method of Chinese medicine composition of the present invention is as follows:
With the Fructus Momordicae charantiae of described weight proportion with Rhizoma Dioscoreae adds water or ethanol extracts, extracting solution is concentrated, dry, make dry extract, be ground into powder, add tea polyphenols, add various conventional adjuvant required when preparing different dosage form, as diluent, disintegrating agent, excipient, binding agent, lubricant, surfactant, filler, antiseptic, stabilizing agent, correctives, thickening agent, fluidizer etc., method of Chinese medicinal with routine is prepared into any peroral dosage form commonly used, as tablet, dispersible tablet, effervescent tablet, oral cavity disintegration tablet, buccal tablet, chewable tablet, capsule, soft capsule, microcapsule, granule, pill, powder, drop pill, slow releasing preparation, controlled release preparation, oral liquid etc.
The preferred for preparation method of Chinese medicine composition of the present invention is as follows:
Twice of the ethanol extraction that the Fructus Momordicae charantiae of described weight proportion and Rhizoma Dioscoreae is added 10 times of amounts and 8 times of amounts 70%, filter, merging filtrate, reclaim ethanol, be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure, make dry extract, be ground into powder, add tea polyphenols, add various conventional adjuvant required when preparing different dosage form, as diluent, disintegrating agent, excipient, binding agent, lubricant, surfactant, filler, antiseptic, stabilizing agent, correctives, thickening agent, fluidizer etc., method of Chinese medicinal with routine is prepared into any peroral dosage form commonly used, as tablet, dispersible tablet, effervescent tablet, oral cavity disintegration tablet, buccal tablet, chewable tablet, capsule, soft capsule, microcapsule, granule, pill, powder, drop pill, slow releasing preparation, controlled release preparation, oral liquid etc.
Each drug mechanism is as follows among the present invention:
Fructus Momordicae charantiae: having clears away heart-fire makes eye bright, the effect of QI invigorating antipyretic, and Fructus Momordicae charantiae contains Charantin, Charantin etc., and pharmacological evaluation proves that Fructus Momordicae charantiae has the effect of tangible blood sugar lowering.
Rhizoma Dioscoreae: have yin nourishing, moisturize, relieving restlessness, effect such as quench the thirst, pharmacological research shows that Rhizoma Dioscoreae has blood fat reducing and blood glucose effect, and the hyperglycemia that epinephrine is caused has remarkable inhibitory action.
Tea polyphenols: be the general name of polyphenols in the Folium Camelliae sinensis, tangible removing free radical and hypoglycemic effect are arranged.
In the present composition, Fructus Momordicae charantiae is less edible in people's diet as the plant of bitterness is arranged, and has wherein contained the trace element of a large amount of diabetes patient's needs; Rhizoma Dioscoreae: have the effect of nourishing YIN to relieve dryness, and the tonic effect is arranged, solved the common weakly problem of diabetes patient, tea polyphenols is strong free radical scavenger, has the hypoglycemic effect of antiinflammatory; Three medicines are harmonious and fundamentally regulate diabetes patient's body comprehensively, improve diabetes patient's physical condition, and three flavor medicines all have very clear and definite blood sugar lowering pharmacology effect, can be with diabetes patient's blood glucose regulation to normal level.
In sum, the present composition have clear away heart-fire make eye bright, relieving restlessness is quenched the thirst, hypoglycemic effect.Can be used for treating diabetes.Can be used for preparing the Chinese medicine and the health product of prevention and treatment diabetes.
Wood invention with respect to prior art have determined curative effect, have no side effect, taking convenience, cheap advantage.
Further set forth the beneficial effect of Chinese medicine composition of the present invention by following experiment.
For showing the hypoglycemic effect of the present invention, entrust the specified health food functional check of Ministry of Public Health mechanism the present invention to be carried out the animal experiment of blood sugar regulation to diabetes.Table 1 is the influence of the present invention to alloxan induced hyperglycemia rat blood sugar, and table 2 is the influence of the present invention to normal rat blood sugar for the influence of the present invention to alloxan induced hyperglycemia rat post-prandial glycemia, table 3.
Table 1 the present invention is to the influence of alloxan induced hyperglycemia rat blood sugar
Group Dosage Animal Blood glucose value mmol/L
g/kg.BW (only) Before being tried Tried 13 days Tried 19 days
Normal group -- 10 3.54±0.85 5.93±0.62 6.31±0.39
Model group -- 10 22.13±6.09 32.85±4.26 35.89±1.93
Low dose group 1.5 10 21.91±5.02 32.54±3.10 33.53±1.95
Middle dosage group 3.0 10 21.88±4.75 32.33±2.61 33.02±1.84
High dose group 9.0 10 21.71±5.10 32.33±3.87 31.79±3.22*
* compare p<0.05 with the hyperglycemia model group
Table 2 the present invention is to the influence of alloxan induced hyperglycemia rat post-prandial glycemia
Figure A200710178508D00051
* p<0.01 of comparing with the hyperglycemia model group
Table 3 the present invention is to the influence of normal rat blood sugar (X ± SD)
Figure A200710178508D00052
Test initial stage F=0.011, P=0.998; Test F=2.102 in latter stage, P=0.118
Table 1-3 result shows that the present invention does not have influence to normal rat blood sugar.High dose of the present invention has tangible reduction effect to the hyperglycemic rat blood glucose due to the alloxan, and middle and high dosage can improve the carbohydrate tolerance by the caused hyperglycemic rat of alloxan.
The specific embodiment
Embodiment 1:
The preparation of the capsule of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 10kg, Rhizoma Dioscoreae 20kg and tea polyphenols 0.5kg, standby;
B) with Fructus Momordicae charantiae and the Rhizoma Dioscoreae ethanol extraction twice with 10 times of amounts and 8 times of amounts 70%, filter, merge filtrate twice, reclaim ethanol, be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is broken into powder, adds tea polyphenols, drying and adjuvant mix, and are prepared into hard capsule.
Embodiment 2:
The preparation of the granule of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 5kg, Rhizoma Dioscoreae 5kg and tea polyphenols 0.1kg, standby;
B) with Fructus Momordicae charantiae and the Rhizoma Dioscoreae ethanol extraction twice with 10 times of amounts and 8 times of amounts 70%, merge filtrate twice, reclaim ethanol, be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is pulverized, added tea polyphenols, add ethanol and make adhesive, add appropriate amount of starch and make filler, make granule.
Embodiment 3:
The preparation of the granule of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 30kg, Rhizoma Dioscoreae 30kg and tea polyphenols 1.5kg, standby;
B) with Fructus Momordicae charantiae and the Rhizoma Dioscoreae ethanol extraction twice with 10 times of amounts and 8 times of amounts 70%, merge filtrate twice, reclaim ethanol, be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is pulverized, added tea polyphenols, add ethanol and make adhesive, add appropriate amount of starch and make filler, make granule.
Embodiment 4:
The preparation of the tablet of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 20kg, Rhizoma Dioscoreae 20kg and tea polyphenols 0.6kg, standby;
B) with Fructus Momordicae charantiae and the Rhizoma Dioscoreae ethanol extraction twice with 10 times of amounts and 8 times of amounts 80%, merge filtrate twice, reclaim ethanol and also be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is pulverized, added tea polyphenols, add adjuvant and make granule, and dry, and compacting is in flakes.
Embodiment 5:
The preparation of the tablet of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 20kg, Rhizoma Dioscoreae 20kg and tea polyphenols 0.6kg, standby;
B) with Fructus Momordicae charantiae and the Rhizoma Dioscoreae ethanol extraction twice with 10 times of amounts and 8 times of amounts 70%, merge filtrate twice, reclaim ethanol and also be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is pulverized, added tea polyphenols, add adjuvant and make granule, and dry, and compacting is in flakes.
Embodiment 6:
The preparation of the effervescent tablet of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 30kg, Rhizoma Dioscoreae 10kg and tea polyphenols 0.3kg, standby;
B) with Fructus Momordicae charantiae and the Rhizoma Dioscoreae ethanol extraction twice with 10 times of amounts and 8 times of amounts 70%, merge filtrate twice, reclaim ethanol and also be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is pulverized, added tea polyphenols, add tartaric acid, sodium bicarbonate, sweeting agent, filler mixing, granulate with dehydrated alcohol, drying adds the lubricant mixing, tabletting, promptly.
Embodiment 7:
The preparation of the dispersible tablet of Chinese medicine composition of the present invention
A) take by weighing Fructus Momordicae charantiae 15kg, Rhizoma Dioscoreae 20kg and tea polyphenols 0.8kg, standby;
B) with Fructus Momordicae charantiae and the Rhizoma Dioscoreae ethanol extraction twice with 10 times of amounts and 8 times of amounts 70%, merge filtrate twice, reclaim ethanol and also be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract;
C) dry extract is pulverized, added tea polyphenols, add disintegrating agent, filler or diluent, mix homogeneously adds binding agent and makes soft material, the system granule, and drying adds part disintegrating agent, fluidizer or lubricant mixing, tabletting, promptly.

Claims (6)

1, a kind of Chinese medicine composition with hypoglycemic activity is characterized in that, it is to be made by following bulk drugs: Fructus Momordicae charantiae 5-30 part, Rhizoma Dioscoreae 5-30 part, tea polyphenols 0.1-1.5 part.
According to the Chinese medicine composition of claim 1, it is characterized in that 2, it is to be made by following bulk drugs: Fructus Momordicae charantiae 5-15 part, Rhizoma Dioscoreae 15-30 part, tea polyphenols 0.3-0.8 part.
According to the Chinese medicine composition of claim 1, it is characterized in that 3, it is to be made by following bulk drugs: 10 parts in Fructus Momordicae charantiae, 20 parts of Rhizoma Dioscoreaes, tea polyphenols 0.5g.
4, the preparation method of claim 1 or 2 or 3 described Chinese medicine compositions is characterized in that, this method is:
With the Fructus Momordicae charantiae of described weight proportion with Rhizoma Dioscoreae adds water or ethanol extracts, extracting solution is concentrated, drying makes dry extract, is ground into powder, adds tea polyphenols, is prepared into active component; The gained active component is mixed with adjuvant, make any medicament on the pharmaceutics.
5, the preparation method of Chinese medicine composition according to claim 4 is characterized in that, it comprises the following steps:
The Fructus Momordicae charantiae of described weight proportion and Rhizoma Dioscoreae are added the ethanol extraction twice of 10 times of amounts and 8 times of amounts 70%, filter, merging filtrate reclaims ethanol, be evaporated to relative density and measure 1.25-1.30 down for 60 ℃, drying under reduced pressure makes dry extract, be ground into powder, add tea polyphenols, be prepared into active component; The gained active component is mixed with adjuvant, make any medicament on the pharmaceutics.
6, claim 1 or 2 or 3 described Chinese medicine compositions are used to prepare prevention and the medicine of treatment diabetes disease or the application of health food.
CNA2007101785080A 2007-11-30 2007-11-30 Traditional Chinese medicine composition with blood-sugar reduction function and preparation method thereof Pending CN101450162A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007101785080A CN101450162A (en) 2007-11-30 2007-11-30 Traditional Chinese medicine composition with blood-sugar reduction function and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007101785080A CN101450162A (en) 2007-11-30 2007-11-30 Traditional Chinese medicine composition with blood-sugar reduction function and preparation method thereof

Publications (1)

Publication Number Publication Date
CN101450162A true CN101450162A (en) 2009-06-10

Family

ID=40732760

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007101785080A Pending CN101450162A (en) 2007-11-30 2007-11-30 Traditional Chinese medicine composition with blood-sugar reduction function and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101450162A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102813195A (en) * 2012-08-06 2012-12-12 广水市东晨农业科技有限公司 Blood glucose-lowering food containing okra and preparation method thereof
CN103027327A (en) * 2012-12-18 2013-04-10 淮阴工学院 Nutritional and healthcare yam beverage and preparation method
CN108371690A (en) * 2018-03-29 2018-08-07 李宏江 Eight kinds are adjusted liquid hypoglycemic food medicine to combine pill

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102813195A (en) * 2012-08-06 2012-12-12 广水市东晨农业科技有限公司 Blood glucose-lowering food containing okra and preparation method thereof
CN103027327A (en) * 2012-12-18 2013-04-10 淮阴工学院 Nutritional and healthcare yam beverage and preparation method
CN108371690A (en) * 2018-03-29 2018-08-07 李宏江 Eight kinds are adjusted liquid hypoglycemic food medicine to combine pill

Similar Documents

Publication Publication Date Title
CN101450166A (en) Traditional Chinese medicine composition with blood-sugar function and preparation method thereof
CN103948786B (en) Traditional Chinese medicine for treating diabetes
CN111840363B (en) Natto-assisted hypoglycemic health-care composition and preparation method and application thereof
CN101450095A (en) Medicine composition with blood-sugar reduction function and preparation method thereof
CN103768152A (en) Osmanthus phenylethanoid glycoside extract, and preparation method and application thereof
CN104666373A (en) Novel use of Eurycoma longifolia Jack
CN101856405B (en) Medicinal composition for treating type II diabetes mellitus and preparation method thereof
CN101450101A (en) Medicine composition with blood-sugar reduction function and preparation method thereof
CN114209758A (en) Traditional Chinese medicine compound composition capable of maintaining blood sugar health level and preparation method and application thereof
CN1329049C (en) Blood sugar- and blood pressure-lowering medicine
CN101433597A (en) Chinese medicinal composition with function for reducing blood sugar and preparation method thereof
CN101450177A (en) Traditional Chinese medicine composition with blood sugar reducing function and preparation method thereof
CN101450162A (en) Traditional Chinese medicine composition with blood-sugar reduction function and preparation method thereof
CN101433667A (en) Pharmaceutical composition with function for reducing blood sugar and preparation method thereof
CN106035849A (en) Blood-pressure-reducing health tea and preparation process thereof
CN107890528B (en) Traditional Chinese medicine composition for treating hyperuricemia and preparation method thereof
CN101491605A (en) Combination with blood sugar reducing function and preparation method thereof
CN101199652B (en) Medicament for treating acute, subacute eczema and preparing method thereof
CN101450174A (en) Medicine composition with blood-sugar reduction function and preparation method thereof
CN101450096A (en) Medicine composition with blood-sugar reduction function and preparation method thereof
CN101491581A (en) Combination with blood sugar reducing function and preparation method thereof
CN104587175A (en) Formula of traditional Chinese medicine for treating diabetes mellitus
CN101491580A (en) Combination with blood sugar reducing function and preparation method thereof
CN115252729B (en) Traditional Chinese medicine composition for treating diabetes and application thereof
CN101491569A (en) Combination with blood sugar reducing function and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090610